Description
2-Fluorodeschloroketamine, commonly referred to as 2F-DCK, is a synthetic dissociative compound structurally related to ketamine and deschloroketamine. It is characterized by the substitution of a fluorine atom on the aromatic ring, a modification that influences its chemical and pharmacological properties. 2F-DCK has not been approved for medical use and is typically encountered in research or analytical contexts.
Compounds in the ketamine-related class are primarily associated with antagonism of the N-methyl-D-aspartate (NMDA) receptor in the central nervous system. NMDA receptor modulation is linked to dissociative, anesthetic, and perceptual effects, though the specific profile and intensity may vary depending on molecular structure and dosage.

Reviews
There are no reviews yet.